Table 1:
Baseline characteristics of the subjects in whom this trial was completed.
|
|
Basal insulin
group (n = 22） |
Premixed
insulin group （n = 21） |
P value |
|
Age (years) |
67.6 ± 8.7 |
72.8 ± 10.5 |
0.088 |
|
Sex (male/female) |
14
/ 8 |
12 / 9 |
0.663 |
|
Body weight （kg） |
60.4 ± 12.1 |
56.7 ± 9.8 |
0.287 |
|
Duration of diabetes (years) |
16.6 ± 8.6 |
21.8 ± 8.8 |
0.058 |
|
Body mass index （kg/m2） |
23.2 ± 3.6 |
23.3 ± 3.0 |
0.959 |
|
HbA1c (%) |
7.87 ± 0.99 |
7.96 ± 1.17 |
0.778 |
|
Insulin dose (U/day) |
24.8 ± 11.1 |
24.8 ± 8.8 |
0.974 |
|
Insulin dose (U/kg/day) |
0.41 ± 0.16 |
0.44 ± 0.16 |
0.455 |
|
Systolic clinic blood pressure (mmHg) |
134.2 ± 16.1 |
135.7 ± 20.1 |
0.801 |
|
Diastolic clinic blood pressure (mmHg) |
75.0 ± 10.3 |
71.1 ± 11.3 |
0.254 |
|
Total cholesterol (mg/dL) |
190.0 ± 49.9 |
188.0 ± 43.5 |
0.887 |
|
Triglyceride (mg/dL) |
135.5 ± 84.7 |
124.5 ± 69.7 |
0.645 |
|
High-density lipoprotein cholesterol (mg/dL) |
59.4 ± 21.3 |
55.3 ± 12.3 |
0.449 |
|
Low-density lipoprotein cholesterol (mg/dL) |
103.5
± 41.1 |
107.7
± 33.9 |
0.715 |
Values
are expressed as means ± S.D.